Storys zum Thema Products
- mehr
Reinventing the Webcam: Roundshot Livecam D2 HD - 66 Million Pixels
mehrPalonosetron effectively prevents emesis and nausea induced by high dose chemotherapy in patients undergoing autologous stem cell transplantation
Lugano/Berlin, Germany (ots) - Single dose palonosetron achieves optimal control of acute emesis in patients receiving multiday-high dose chemotherapy before autologous stem cell transplantation. The addition of a second dose of palonosetron after 48 hours significantly reduces the detrimental impact of ...
mehrHelsinn partners with EISAI for Gelclair in Italy
Lugano (ots) - The Swiss pharmaceutical group Helsinn and Eisai Italy, subsidiary of the Japanese pharmaceutical company, have signed a licensing agreement for the commercialization of the medical device Gelclair in Italy. Helsinn is the worldwide licensor of Gelclair, a viscous, concentrated, bioadherent oral gel with a mechanical protective action, which relieves pain by adhering to the mucosal surface of ...
mehrSIX Multipay now offers the acceptance and processing of Diners Club and Discover
Zurich (ots) - SIX Multipay Ltd, the leading acquiring company in Switzerland, will in the future offer Swiss merchants the acceptance and processing of Diners Club and Discover credit cards. SIX Multipay is thereby adding two leading credit card brands to its range of products, which until now has consisted of Visa, MasterCard and JCB credit cards, V Pay, Visa ...
mehrAlbis Technologies achieves MEF-18 Certification
Zurich (ots) - Albis Technologies, the leading provider of circuit emulation solutions, has been awarded the MEF-18 certification for Circuit Emulation Services over Ethernet. Albis Technologies' comprehensive Universal Line Access Family (ULAF+) has passed the conformance test procedures of the MEF-approved Circuit Emulation Services over Ethernet (CESoETH) certification program. In the tests, Albis' ...
mehrSupportive care in cancer: palonosetron recommended 5-HT3 antagonist for emesis prevention by MASCC/ESMO
Lugano (ots) - Anticipated at the Rome 2009 MASCC International Symposium the outcome of the 2009 joint MASCC (Multinational Association for Supportive Care in Cancer)/ESMO (European Society of Medical Oncology) antiemetic guideline update meeting New important acknowledgment for palonosetron, the second ...
mehr"Swiss-made? direct debits for Europe - SIX Group launches new SEPA service for the European market
Zurich/Frankfurt, Germany (ots) - SIX Group, the Swiss financial market infrastructure provider, will offer a SEPA-compatible direct debit service in cooperation with the SECB Swiss Euro Clearing Bank, Frankfurt, starting November 2, 2009. The offer is aimed at financial institutions in Switzerland and 30 ...
mehrECOLABORATION(TM) Initiative Directs Nespresso to Sustainable Success
Barcelona, Spain (ots) - Commitment to ambitious coffee, capsules and carbon sustainability targets Nestlé Nespresso SA today launched Ecolaboration(TM), a platform for partnership with key stakeholders to improve the sustainability throughout the Nespresso value chain. With the launch the company extends its commitment to three major targets that will ...
mehrWISeKey lands CH 4.5 Million in Anti-Counterfeiting and New Generation Digital Identification technology contracts
Geneva (ots) - WISeKey SA announced today it has received orders in June totaling CHF 4.5 million from several clients from its anti-counterfeiting and Digital Identity system that safeguards and verifies the authenticity of luxury goods and protects the digital identity of users. "Together with the ...
mehrSingle dose Palonosetron prevents emesis induced by chemotherapy in non Hodgkin's lymphoma patients
Berlin, Germany (ots) - Single dose palonosetron is effective and safe in preventing chemotherapy-induced nausea and vomiting (CINV) in patients with aggressive non-Hodgkin's lymphomas who undergo moderately emetogenic chemotherapy. Data presented today at the European Haematology Association Congress in Berlin, Germany New data presented today at the EHA ...
mehrThe Association for International Mobility (AIM) and the Hassan II Foundation to establish a Services Platform for Moroccans living abroad (SPM) based on WISeKey technology
Geneva, Switzerland / Rabat, Marocco (ots) - Today in Rabat, the Association for International Mobility (AIM) and the Hassan II Foundation, will present a new Internet-based Services Platform for Moroccans Living Abroad (SPM), relying on WISeKey secure identity technology and codes protected by OISTE. "This ...
mehrBio-Design Computer Mouse
mehrPalonosetron "preferred" 5-HT3 antagonist for emesis prevention in oncology patients receiving highly emetogenic chometherapy
Lugano, Switzerland (ots) - A new release of the NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology on Antiemesis recommends palonosetron as the "preferred" 5-HT3 antagonist in combination with aprepitant and dexamethasone for prevention of emesis in highly emetic risk ...
mehrAleXora watches: Breaking the daily round
mehrHelsinn Healthcare SA: Palonosetron warrants adequate caloric intake in oncology patients receiving high emetogenic chemotherapy
Zurich, Switzerland (ots) - A new, innovative study shows that a single dose of palonosetron, the second generation 5-HT3 antagonist, plus dexamethasone not only prevents chemotherapy-induced nausea and vomiting (CINV), but also allows adequate caloric intake in oncology patients. Data presented today at the ESMO ...
mehrLaunch of BookingDooH.com - The only global "Digital-out-of-Home" online planning and booking platform
Geneva (ots) - Neo Booking SA, is launching the first global online planning and booking platform for "digital-out-of-home" advertising, called BookingDooH ( www.bookingdooh.com ). BookingDooh is a free virtual marketplace for Digital-out-of-Home operators and media buyers. The platform provides a clear and ...
mehr2008: A Growth Year for the La Prairie Group
mehrNew features in Doodle connect world's most popular online scheduling tool with all major calendar systems
Easy scheduling tool Doodle.com frees users to focus on core business activities. Zurich (ots) - Doodle, the popular Web 2.0 scheduling tool, has announced exciting new features for personal and business users, which help its "polls", or tabulated meeting requests, to further extinguish the common time-burner ...
mehrAlbis Technologies: "Active RFID" in actual use
Zurich (ots) - One of the attractions of this year's CeBIT show (March 3 - 8) comes from Albis Technologies, provider of groundbreaking RFID components and services, with its real-world look at the latest developments and potential applications of its "Active RFID" technology. Authentic live presentations will show visitors how, for example, inventory can be carried out without any manual counting. ...
mehrPieris reports development progress for Anticalin® PRS-050, a next generation VEGF antagonist / Expansion of management team announced to support program success
Freising-Weihenstephan, Germany (ots) - Pieris AG, a biopharmaceutical company developing Anticalins®, a novel class of targeted human protein therapeutics, reports today that it has made significant progress in the development of its Anticalin® candidate PRS-050, a potent VEGF antagonist with broad ...
mehrWISeKey devises an anticounterfeiting system that safeguards and verifies the authenticity of luxury goods
Geneva (ots) - Every product made by a luxury goods manufacturer -a watch, handbag, piece of jewellery, etc.- would be accompanied and sold with a smart device, such as a SmartCard, containing the encrypted full details of the product, ie registration number, bar code, date and place of manufacture, etc. ...
mehrJoint development of vaccines against avian flu: AmVac AG cooperates with National Health Research Institutes in Taiwan
Zug, Switzerland (ots) - Swiss AmVac AG establishes comprehensive collaboration with the National Health Research Institutes in Taiwan to combat H5N1. H5N1/Influenza A is a flu virus known colloquially as "avian flu". "Avian flu" first occurred in Asia, and was transmitted to humans in a number of cases. ...
mehrHelsinn Birex Pharmaceuticals receives IMP Licence for storage and packaging of Clinical Trial Materials
Lugano, Switzerland (ots) - Helsinn is delighted to announce that its drug product manufacturing facility in Dublin, Ireland, Helsinn Birex Pharmaceuticals, has recently obtained an authorisation for Manufacture of Investigational Medicinal Products (IMP) for products for human use from the Irish Medicines Board ...
mehrTechnology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer"s Disease Drug Development
- Indication: The full press release can be downloaded free of charge under: http://www.presseportal.ch/de/pm/100007839 - Ecublens/Lausanne, Switzerland (ots) - - AC Immune selected as Technology Pioneer 2009 by the ...
Ein DokumentmehrGE Money Bank: M...MasterCard - Top of the Credit Card Hit Parade
mehrHelsinn Healthcare and Zealnd Pharma sign a partnering agreement for ZP1846, a novel GLP-2 agonist
Lugano, Switzerland (ots) - Helsinn Healthcare's Top management today announced that it has signed a partnering agreement with Zealand Pharma, for the development and worldwide commercialization of ZP1846, a GLP-2 (glucagon-like peptide-2) receptor agonist which provides a novel way to treat chemotherapy-induced diarrhea (CID), a debilitating condition affecting ...
mehrMailCleaner: Fighting spam just got easier
St-Sulpice (ots) - More than 90% of the messages that reach enterprise mail servers are unwanted. This disquieting rate demands filtering solutions of increasing complexity-complex in terms of message processing, but simple in terms of daily use. Throughout the development cycle for Version 3 of MailCleaner, the focus was on ergonomics and the user experience. "We've made good use of the numerous suggestions ...
mehrConvincing results of Solianis' multisensor system in home-use trial
Zurich, (ots) - Solianis' multisensor system for non-invasive Continuous Glucose Monitoring is currently being tested by diabetic patients in the home and work environment. 12 patients have completed a 10-day trial aimed at assessing system reliability. Results indicate that the system tracks glucose in home-use settings and is sensitive to hypoglycemic glucose ...
mehrThe computer mouse becomes more comfortable
mehr